Abstract LB107: Novel Transcriptional Signatures Associated with Antitumor Activity in Vidutolimod (Vidu)-Treated Patients (pts) with Anti-Pd-1-refractory Melanoma and Non-Small Cell Lung Cancer (NSCLC)
CANCER RESEARCH（2022）
Key words
Biomarkers for Immunotherapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined